|
PPFIA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.655350E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.003700E-03 |
| Normal-vs-Stage2 |
2.069500E-02 |
| Normal-vs-Stage3 |
1.338840E-01 |
| Normal-vs-Stage4 |
1.491900E-02 |
| Stage1-vs-Stage2 |
4.795600E-01 |
| Stage1-vs-Stage3 |
1.783190E-01 |
| Stage1-vs-Stage4 |
9.538600E-01 |
| Stage2-vs-Stage3 |
1.603030E-01 |
| Stage2-vs-Stage4 |
5.499800E-01 |
| Stage3-vs-Stage4 |
2.893000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.574040E-02 |
| Normal-vs-AfricanAmerican |
7.550300E-02 |
| Normal-vs-Asian |
1.521980E-02 |
| Caucasian-vs-AfricanAmerican |
4.014000E-01 |
| Caucasian-vs-Asian |
3.548800E-01 |
| AfricanAmerican-vs-Asian |
8.982400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.081900E-02 |
| Normal-vs-Female |
1.539080E-03 |
| Male-vs-Female |
6.114600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.795300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.234330E-02 |
| Normal-vs-Age(61-80Yrs) |
4.657800E-02 |
| Normal-vs-Age(81-100Yrs) |
7.023400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.693800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.200000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.517990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.709200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.439200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.805200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.929800E-01 |
| Classical-VS-Follicular |
9.849400E-01 |
| Classical-VS-Other |
8.911600E-01 |
| Classical-VS-Normal |
1.040040E-03 |
| Tall-VS-Follicular |
8.127200E-01 |
| Tall-VS-Other |
7.779200E-01 |
| Tall-VS-Normal |
5.461600E-02 |
| Follicular-VS-Other |
8.768600E-01 |
| Follicular-VS-Normal |
2.505700E-02 |
| Other-VS-Normal |
1.198610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.800150E-02 |
| Normal-vs-N1 |
2.057400E-01 |
| N0-vs-N1 |
5.228000E-01 |
|
|
